NPSP NPS Pharmaceutical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NPSP NPS Pharmaceutical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTDEC who wrote (59)	12/30/1999 9:41:00 AM
From: biowa	Read Replies (1) of 363

Walter, Thanks! I have to admit I agree with LIA that the near-term impact is unclear, especially since it is unclear what portion of this new news. In addition, I see that 1506 continues to be MIA. The last paragraph refers to an ongoing clinical development program in epilepsy and bipolar disorders, obviously 1776; nothing on stroke. Perhaps the key adjective is ongoing and 1506 is merely waiting for partnering to take it forward. All in all, though, IP is nice and the ring of this is that it is fairly solid. BTW, in case I haven't said it here before, I tend to err on the side of balance in stocks I like; so don't worry about any negative tone, this is nice news and I'm still LONG. biowa PS - and obviously Mr. Market likes it: RTQ 11 1/4

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next